ATYR PHARMA, INC. (ATYR) Net income 2016–2025
ATYR PHARMA, INC. (ATYR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$74.1MFY2025 · since FY2016: -$57.9M → -$74.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$74.1M | -15.8% |
| FY2024 | -$64.0M | -27.1% |
| FY2023 | -$50.4M | -11.1% |
| FY2022 | -$45.3M | -34.3% |
| FY2021 | -$33.8M | -108.1% |
| FY2020 | -$16.2M | +0.0% |
| FY2019 | -$16.2M | +53.0% |
| FY2018 | -$34.5M | +28.4% |
| FY2017 | -$48.2M | +16.7% |
| FY2016 | -$57.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice